Published in Proc Natl Acad Sci U S A on February 13, 2001
Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome. Am J Hum Genet (2002) 1.61
Current status of the congenital myasthenic syndromes. Neuromuscul Disord (2011) 1.60
Myasthenic syndrome caused by mutation of the SCN4A sodium channel. Proc Natl Acad Sci U S A (2003) 1.50
Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol (2015) 1.44
The therapy of congenital myasthenic syndromes. Neurotherapeutics (2007) 1.29
Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. Proc Natl Acad Sci U S A (2004) 1.29
What have we learned from the congenital myasthenic syndromes. J Mol Neurosci (2009) 1.29
The epithelial cholinergic system of the airways. Histochem Cell Biol (2008) 1.17
Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence. Neuropsychopharmacology (2010) 1.17
Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome. J Med Genet (2009) 1.08
Congenital myasthenia-related AChR delta subunit mutation interferes with intersubunit communication essential for channel gating. J Clin Invest (2008) 1.04
Choline acetyltransferase structure reveals distribution of mutations that cause motor disorders. EMBO J (2004) 1.02
Acetylcholine receptor delta subunit mutations underlie a fast-channel myasthenic syndrome and arthrogryposis multiplex congenita. J Clin Invest (2001) 1.02
Recurrent deletions and reciprocal duplications of 10q11.21q11.23 including CHAT and SLC18A3 are likely mediated by complex low-copy repeats. Hum Mutat (2011) 1.01
Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients. Neurology (2009) 1.00
Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations. J Neurol (2011) 0.99
Function of neuromuscular synapses in the zebrafish choline-acetyltransferase mutant bajan. J Neurophysiol (2008) 0.97
Further observations in congenital myasthenic syndromes. Ann N Y Acad Sci (2008) 0.95
Myasthenic syndrome AChRα C-loop mutant disrupts initiation of channel gating. J Clin Invest (2012) 0.95
Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease. Hum Genet (2003) 0.91
DPAGT1 myasthenia and myopathy: genetic, phenotypic, and expression studies. Neurology (2014) 0.90
New horizons for congenital myasthenic syndromes. Ann N Y Acad Sci (2012) 0.87
Functional consequences and structural interpretation of mutations of human choline acetyltransferase. Hum Mutat (2011) 0.85
Nonvesicular release of acetylcholine is required for axon targeting in the Drosophila visual system. Proc Natl Acad Sci U S A (2004) 0.84
High throughput genetic analysis of congenital myasthenic syndromes using resequencing microarrays. PLoS One (2007) 0.84
Genetic variants in the choline acetyltransferase (ChAT) gene are modestly associated with normal cognitive function in the elderly. Genes Brain Behav (2011) 0.84
Impaired Presynaptic High-Affinity Choline Transporter Causes a Congenital Myasthenic Syndrome with Episodic Apnea. Am J Hum Genet (2016) 0.83
Inherited disorders of the neuromuscular junction: an update. J Neurol (2014) 0.83
Congenital myasthenic syndromes in 2012. Curr Neurol Neurosci Rep (2012) 0.83
PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome. Neurology (2014) 0.83
GFPT1-myasthenia: clinical, structural, and electrophysiologic heterogeneity. Neurology (2013) 0.83
Comparative study of korean white, red, and black ginseng extract on cholinesterase inhibitory activity and cholinergic function. J Ginseng Res (2011) 0.83
Congenital myasthenic syndromes: Natural history and long-term prognosis. Ann Indian Acad Neurol (2013) 0.82
Variants in SLC18A3, vesicular acetylcholine transporter, cause congenital myasthenic syndrome. Neurology (2016) 0.82
Identification of mutations in the MYO9A gene in patients with congenital myasthenic syndrome. Brain (2016) 0.81
Congenital myasthenic syndrome with episodic apnea. Pediatr Neurol (2009) 0.80
Nuclear choline acetyltransferase activates transcription of a high-affinity choline transporter. J Biol Chem (2010) 0.79
The effect of prenatal nicotine on mRNA of central cholinergic markers and hematological parameters in rat fetuses. Int J Dev Neurosci (2008) 0.78
Therapeutic strategies in congenital myasthenic syndromes. Neurotherapeutics (2008) 0.78
Chronic acetylcholinesterase overexpression induces multilevelled aberrations in mouse neuromuscular physiology. J Physiol (2003) 0.77
A single mutation in the acetylcholine receptor δ-subunit causes distinct effects in two types of neuromuscular synapses. J Neurosci (2014) 0.77
Diagnosis of muscle diseases presenting with early respiratory failure. J Neurol (2014) 0.76
Limb girdle myasthenia with digenic RAPSN and a novel disease gene AK9 mutations. Eur J Hum Genet (2016) 0.75
Determination of allelic expression of SNP rs1880676 in choline acetyltransferase gene in HeLa cells. Neurosci Lett (2013) 0.75
Alteration in cellular acetylcholine influences dauer formation in Caenorhabditis elegans. BMB Rep (2014) 0.75
Novel synaptobrevin-1 mutation causes fatal congenital myasthenic syndrome. Ann Clin Transl Neurol (2017) 0.75
Neck muscle afferents influence oromotor and cardiorespiratory brainstem neural circuits. Brain Struct Funct (2014) 0.75
An ocular motility conundrum. BMJ Case Rep (2014) 0.75
Association of Choline Acetyltransferase Gene Polymorphisms (SNPs rs868750G/A, rs1880676G/A, rs2177369G/A and rs3810950G/A) with Alzheimer's Disease Risk: A Meta-Analysis. PLoS One (2016) 0.75
Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome: Molecular Findings and Genotype-Phenotype Correlations. Hum Mutat (2015) 0.75
Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol Cell Biol (1986) 7.11
A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem (1975) 4.29
Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit. Proc Natl Acad Sci U S A (1995) 1.92
Choline acetyltransferase-deficient mutants of the nematode Caenorhabditis elegans. Genetics (1984) 1.89
Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus. J Biol Chem (1994) 1.54
Identification and characterization of the high-affinity choline transporter. Nat Neurosci (2000) 1.40
Kinesin-II is required for axonal transport of choline acetyltransferase in Drosophila. J Cell Biol (1999) 1.33
Molecular cloning of a human, hemicholinium-3-sensitive choline transporter. Biochem Biophys Res Commun (2000) 1.30
The cholinergic gene locus. J Neurochem (1998) 1.27
Congenital myasthenic syndromes: I. Deficiency and short open-time of the acetylcholine receptor. Muscle Nerve (1993) 1.27
Complete sequence of a cDNA encoding an active rat choline acetyltransferase: a tool to investigate the plasticity of cholinergic phenotype expression. J Neurosci Res (1989) 1.15
Congenital myasthenic syndromes. Electroencephalogr Clin Neurophysiol Suppl (1987) 1.11
Congenital end-plate acetylcholinesterase deficiency caused by a nonsense mutation and an A-->G splice-donor-site mutation at position +3 of the collagenlike-tail-subunit gene (COLQ): how does G at position +3 result in aberrant splicing? Am J Hum Genet (1999) 1.08
Clinical syndromes of myasthenia in infancy and childhood. A review. Arch Neurol (1978) 1.08
The slow axonal transport of cytoskeletal proteins. Curr Opin Cell Biol (1998) 1.05
Vesicular neurotransmitter transport and the presynaptic regulation of quantal size. Curr Opin Neurobiol (1998) 1.05
Choline acetyltransferase and acetylcholine levels in Drosophila melanogaster: a study using two temperature-sensitive mutants. J Neurosci (1985) 1.00
cDNA cloning and complete sequence of porcine choline acetyltransferase: in vitro translation of the corresponding RNA yields an active protein. Proc Natl Acad Sci U S A (1987) 0.98
Functional analysis of conserved histidines in choline acetyltransferase by site-directed mutagenesis. J Neurochem (1993) 0.98
Synaptic vesicle abnormality in familial infantile myasthenia. Neurology (1987) 0.97
Redesign of choline acetyltransferase specificity by protein engineering. J Biol Chem (1998) 0.95
Identification of an active site arginine in rat choline acetyltransferase by alanine scanning mutagenesis. J Biol Chem (1995) 0.92
Complementary DNAs for choline acetyltransferase from spinal cords of rat and mouse: nucleotide sequences, expression in mammalian cells, and in situ hybridization. Brain Res Mol Brain Res (1990) 0.90
Re-evaluation of the kinetic mechanism of the choline acetyltransferase reaction. J Biol Chem (1977) 0.90
Familial infantile myasthenia. Arch Neurol (1980) 0.90
Human choline acetyltransferase mRNAs with different 5'-region produce a 69-kDa major translation product. Brain Res Mol Brain Res (1997) 0.89
Nuclear localization of the 82-kDa form of human choline acetyltransferase. J Biol Chem (1999) 0.88
Arthrogryposis multiplex congenita due to congenital myasthenia. Dev Med Child Neurol (1980) 0.88
A complementary DNA for human choline acetyltransferase induces two forms of enzyme with different molecular weights in cultured cells. Brain Res Mol Brain Res (1992) 0.86
Upstream sequencing and functional characterization of the human cholinergic gene locus. J Mol Neurosci (1997) 0.85
Human choline acetyltransferase gene: localization of alternative first exons. J Neurosci Res (1995) 0.84
Familial infantile myasthenia gravis. Report of three cases with follow-up until adult life. Arch Neurol (1985) 0.81
Human choline acetyltransferase (CHAT): partial gene sequence and potential control regions. Genomics (1992) 0.81
Cloning of the rat gene encoding choline acetyltransferase, a cholinergic neuron-specific marker. Proc Natl Acad Sci U S A (1992) 0.81
Myasthenia gravis in the newborn. Pediatrics (1960) 0.80
Familial infantile myasthenia gravis: a cause of sudden death in young children. J Pediatr (1975) 0.79
Familial infantile myasthenia: a neuromuscular cause of respiratory failure. Childs Nerv Syst (1994) 0.79
Familial infantile myasthenia: confusion in terminology. Neuromuscul Disord (1999) 0.79
Familial infantile myasthenia gravis: a preventable cause of sudden death. South Med J (1985) 0.78
Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology (1975) 2.89
Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain (2005) 2.89
Intracranial pressure in African children with cerebral malaria. Lancet (1991) 2.67
Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol (1984) 2.66
Current results of the retrosigmoid approach to acoustic neurinoma. J Neurosurg (1992) 2.62
Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron (1995) 2.55
Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol (1990) 2.42
Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome. Science (1973) 2.34
Fingerprint body myopathy, a newly recognized congenital muscle disease. Mayo Clin Proc (1972) 2.34
Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit. Neuron (1996) 2.27
Uniparental paternal disomy in Angelman's syndrome. Lancet (1991) 2.26
Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. J Gen Physiol (1997) 2.25
Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell (1994) 2.15
EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. Eur J Neurol (2008) 2.12
The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med (1990) 2.06
Inherited prothrombotic states and ischaemic stroke in childhood. J Neurol Neurosurg Psychiatry (1998) 2.06
Polymyositis mediated by T lymphocytes that express the gamma/delta receptor. N Engl J Med (1991) 2.00
Noninvasive measurement of concurrent single-kidney perfusion, glomerular filtration, and tubular function. Am J Physiol Renal Physiol (2001) 1.99
Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit. Proc Natl Acad Sci U S A (1995) 1.92
Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol (1989) 1.89
POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology (2004) 1.89
Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme. Proc Natl Acad Sci U S A (1998) 1.85
Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc (1977) 1.85
The immunobiology of muscle. Immunol Today (1994) 1.83
Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci U S A (1989) 1.82
Inclusion body myositis. Observations in 40 patients. Brain (1989) 1.82
Acetylcholinesterase of human erythrocytes and neuromuscular junctions: homologies revealed by monoclonal antibodies. Proc Natl Acad Sci U S A (1982) 1.79
Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. Neurology (1977) 1.78
AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis. Neurology (2000) 1.77
Myasthenia gravis and myasthenic syndromes. Ann Neurol (1984) 1.77
Anti-MuSK autoantibodies block binding of collagen Q to MuSK. Neurology (2011) 1.77
Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies. Brain (1970) 1.72
The spectrum and diagnosis of acid maltase deficiency. Neurology (1973) 1.71
Intracranial hypertension in Africans with cerebral malaria. Arch Dis Child (1997) 1.71
Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci U S A (1983) 1.71
Serum choline activates mutant acetylcholine receptors that cause slow channel congenital myasthenic syndromes. Proc Natl Acad Sci U S A (1999) 1.68
Brain swelling and ischaemia in Kenyans with cerebral malaria. Arch Dis Child (1994) 1.67
Relationship between symptoms and disordered continence mechanisms in women with idiopathic faecal incontinence. Gut (2005) 1.67
Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology (1978) 1.63
Coma scales for children with severe falciparum malaria. Trans R Soc Trop Med Hyg (1997) 1.63
Histometric analysis of the ultrastructure of the neuromuscular junction in myasthenia gravis and in the myasthenic syndrome. Ann N Y Acad Sci (1971) 1.62
Premutation allele pool in myotonic dystrophy type 2. Neurology (2008) 1.61
New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet (1996) 1.60
Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit. J Neurosci (1997) 1.59
Carotid dissection causing stroke in a child with migraine. BMJ (1997) 1.59
Late-onset lower motor neuronopathy: a new autosomal dominant disorder. Neurology (2011) 1.57
Multicore disease. A recently recognized congenital myopathy associated with multifocal degeneration of muscle fibers. Mayo Clin Proc (1971) 1.56
Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies. J Exp Med (1976) 1.53
Failure of inactivation of Duchenne dystrophy X-chromosome in one of female identical twins. Neurology (1977) 1.53
A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel. Ann Neurol (1982) 1.52
Congenital myasthenic syndrome caused by a mutation in the Ets-binding site of the promoter region of the acetylcholine receptor epsilon subunit gene. Neuromuscul Disord (1999) 1.52
Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability. Neurology (1999) 1.52
Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children. Neurology (2004) 1.49
Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T-->G) mutation in a majority of patients and a novel IVS10 (+1GT-->CT) mutation. Hum Mol Genet (1994) 1.49
Zaspopathy in a large classic late-onset distal myopathy family. Brain (2007) 1.47
NICE and warm. Br J Anaesth (2008) 1.47
The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain (2008) 1.45
Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor epsilon subunit gene: identification and functional characterization of six new mutations. Hum Mol Genet (1997) 1.45
Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration. Neurology (1991) 1.45
Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol (1984) 1.43
The relation between pump flow rate and pulsatility on cerebral hemodynamics during pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg (1997) 1.43
Outcome after ischaemic stroke in childhood. Dev Med Child Neurol (2000) 1.43
The effects of quality improvement interventions on inhospital mortality after acute myocardial infarction. Med J Aust (2001) 1.42
Acetylcholine receptor M3 domain: stereochemical and volume contributions to channel gating. Nat Neurosci (1999) 1.42
Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls. J Neuroimmunol (1995) 1.42
Distinct muscle imaging patterns in myofibrillar myopathies. Neurology (2008) 1.41
Stöckert roller pump generated pulsatile flow: cerebral metabolic changes in adult cardiopulmonary bypass. Perfusion (1997) 1.40
Far-field auditory brainstem response in neurotologic surgery. Am J Otol (1996) 1.40
Ondansetron compared with metoclopramide in the treatment of PONV. Br J Anaesth (1998) 1.40
The relation between arterial oxygen tension and cerebral blood flow during cardiopulmonary bypass. Eur J Cardiothorac Surg (1997) 1.38
The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features. Neurology (1975) 1.38
High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany. J Neurol (2008) 1.37
A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release. Ann Neurol (1977) 1.36
Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis. J Neuropathol Exp Neurol (1980) 1.35
Perturbations of cerebral hemodynamics in Kenyans with cerebral malaria. Pediatr Neurol (1996) 1.33
Analysis of growth of multicellular tumour spheroids by mathematical models. Cell Prolif (1994) 1.33
Autophagic glycogenosis of late onset with mitochondrial abnormalities: light and electron microscopic observations. Mayo Clin Proc (1968) 1.33
The plasma membrane calcium pump displays memory of past calcium spikes. Differences between isoforms 2b and 4b. J Biol Chem (2001) 1.32
Magnetic resonance imaging of anatomic and dynamic defects of the pelvic floor in defecatory disorders. Am J Gastroenterol (2003) 1.31
Transcranial measurement of blood velocities in the basal cerebral arteries using pulsed Doppler ultrasound: velocity as an index of flow. Ultrasound Med Biol (1986) 1.31
Carnitine metabolism and inborn errors. J Inherit Metab Dis (1984) 1.30
Experimental chloroquine myopathy. J Neuropathol Exp Neurol (1970) 1.30
The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study. Ann N Y Acad Sci (1976) 1.30
Azathioprine with prednisone for polymyositis. A controlled, clinical trial. Ann Intern Med (1980) 1.29
Thymoma. Mayo Clin Proc (1993) 1.29
Secondary calpain3 deficiency in 2q-linked muscular dystrophy: titin is the candidate gene. Neurology (2001) 1.28
The earliest pathologic alterations in dysferlinopathy. Neurology (2001) 1.28
Myofibrillar myopathy with abnormal foci of desmin positivity. I. Light and electron microscopy analysis of 10 cases. J Neuropathol Exp Neurol (1996) 1.27
Congenital myasthenic syndromes: I. Deficiency and short open-time of the acetylcholine receptor. Muscle Nerve (1993) 1.27
Late-onset rod myopathy (a new syndrome?): light and electron microscopic observations in two cases. Mayo Clin Proc (1966) 1.25
Amyloid myopathy: an underdiagnosed entity. Ann Neurol (1998) 1.25
Coexistence in human and primate neuromuscular junctions of enzymes synthesizing acetylcholine, catecholamine, taurine, and gamma-aminobutyric acid. Proc Natl Acad Sci U S A (1982) 1.25